- Home
- BAH vs RGC Comparison
BAH vs RGC Comparison
Compare BAH & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAH | RGC |
|---|---|---|
| Founded | 1914 | 2014 |
| Country | United States | Hong Kong |
| Employees | 31500 | N/A |
| Industry | Professional Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 11.5B |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BAH | RGC |
|---|---|---|
| Price | $72.53 | $5.72 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $97.00 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 536.5K |
| Earning Date | 05-22-2026 | 10-31-2025 |
| Dividend Yield | ★ 3.09% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.63 | N/A |
| Revenue | ★ $11,217,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.14 | N/A |
| P/E Ratio | $9.55 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $59.50 | $4.51 |
| 52 Week High | $114.48 | $69.00 |
Technical Indicators
Market Signals| Indicator | BAH | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 66.41 | 32.41 |
| Support Level | $68.84 | $4.51 |
| Resistance Level | $82.42 | $29.26 |
| Average True Range (ATR) | 2.56 | 0.79 |
| MACD | 1.31 | 0.66 |
| Stochastic Oscillator | 82.37 | 36.12 |
Price Performance
Historical ComparisonAbout BAH Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corp provides technology solutions in areas such as artificial intelligence, cybersecurity, and related fields. The company serves U.S. federal government agencies, commercial clients, and select international customers. It also provides technologies to evolve defense missions and delivers solutions to warfighters in the digital battlespace.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.